Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer

2021 ◽  
Vol 41 (2) ◽  
pp. 869-876
Author(s):  
MAX R. CLEVERS ◽  
ELISABETH A. KASTELIJN ◽  
BAS J.M. PETERS ◽  
HANS KELDER ◽  
FRANZ M.N.H. SCHRAMEL
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Serum Biomarker ◽  
Ca 125 ◽  
Small Cell Lung ◽  
Response Predictors

scholarly journals Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer

2020 ◽  
Vol 21 (22) ◽  
pp. 8782
Author(s):  
Young-Ho Ahn ◽  
Yoon Ho Ko
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Epithelial To Mesenchymal Transition ◽  
Small Cell ◽  
Small Cell Lung ◽  
Mesenchymal Transition ◽  
Therapeutic Implications ◽  
Metastatic Colonization ◽  
Response Predictors

microRNAs (miRNAs), endogenous suppressors of target mRNAs, are deeply involved in every step of non-small cell lung cancer (NSCLC) development, from tumor initiation to progression and metastasis. They play roles in cell proliferation, apoptosis, angiogenesis, epithelial-to-mesenchymal transition, migration, invasion, and metastatic colonization, as well as immunosuppression. Due to their versatility, numerous attempts have been made to use miRNAs for clinical applications. miRNAs can be used as cancer subtype classifiers, diagnostic markers, drug-response predictors, prognostic markers, and therapeutic targets in NSCLC. Many challenges remain ahead of their actual clinical application; however, when achieved, the use of miRNAs in the clinic is expected to enable great progress in the diagnosis and treatment of patients with NSCLC.

scholarly journals Prognostic significance of serum ca 125 antigen assay in patients with non-small cell lung cancer

Cancer ◽  
1994 ◽  
Vol 73 (5) ◽  
pp. 1368-1376 ◽  
Author(s):  
Manuel Diez ◽  
Javier Granell ◽  
Antonio Torres ◽  
Ana Gomez ◽  
Josè L. Balibrea ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Significance ◽  
Small Cell ◽  
Ca 125 ◽  
Small Cell Lung ◽  
Antigen Assay ◽  
Ca 125 Antigen

Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)

2011 ◽  
Vol 12 (3) ◽  
pp. 172-179 ◽  
Author(s):  
Susana Cedrés ◽  
Isaac Nuñez ◽  
Marina Longo ◽  
Pablo Martinez ◽  
Eva Checa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tumor Markers ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Ca 125 ◽  
Small Cell Lung ◽  
Serum Tumor Markers ◽  
Worse Prognosis

Evaluation of serum ca 125 as a tumor marker in non-small cell lung cancer

Cancer ◽  
1991 ◽  
Vol 67 (1) ◽  
pp. 150-154 ◽  
Author(s):  
M. Diez ◽  
F. J. Cerdàn ◽  
M. D. Ortega ◽  
A. Torres ◽  
A. Picardo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tumor Marker ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Ca 125 ◽  
Small Cell Lung

scholarly journals Tissue and Serum Biomarker Results from the Phase II Innovations Study in Non-Small Cell Lung Cancer (NSCLC)

2012 ◽  
Vol 23 ◽  
pp. ix390
Author(s):  
N. Reinmuth ◽  
S.J. Scherer ◽  
R. Penzel ◽  
P. Schnabel ◽  
M. Meister ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Serum Biomarker ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document